Trending
-
INDIA & NOT CHINA WILL BE THE PREFFERED DESTINATION FOR INVESTMENT & RESEARCH
INDIA & NOT CHINA WILL BE THE PREFFERED DESTINATION FOR…
Read more -
Indian Pharma CRAMS sector valued at $8.2 Billion with 41.4% growth trajectory, Set To Triplicate global average of 12.6%
Sunday, 12th Augst 2012, Mumbai, Maharashtra : 5th Annual Pharmaceutical…
Read more -
Aanjaneya Lifecare Eyes European Market, To Forge Collaborate Research with a German Pharma Major
Middle East, Gulf & African Continents top on Agenda post…
Read more